Laboratory evaluation demonstrated profound hypophosphatemia, elevated FGF23 levels, and reduced 1,25-dihydroxy vitamin D. Given the patient’s elevated surgical risk, percutaneous cryoablation of the tumor was performed, resulting in normalization of serum phosphate levels and resolution of clinical symptoms. The gene discussed is FGF23; the disease is hypophosphatemia.